Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3897-3900

  Al Lahham, Adnan ^a,c   Appelbaum, Peter C ^b   Van Linden, Mark Der ^a   Reinert, Ralf René ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c GERMAN JORDANIAN UNIVERSITY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; ERMB GENE; EUROPE; GENE SEQUENCE; GENOTYPE; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EUROPE; GENOTYPE; HUMANS; KETOLIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE;

EID: 33750603828     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00057-06     Document Type: Article

References (23)

1. Ackermann, G., and A. C. Rodloff. 2003. Drugs of the 21st century: telithromycin (HMR 3647)-the first ketolide. J. Antimicrob. Chemother. 51:497-511.
2. 1a.Al-Lahham, A., and R. R. Reinert 2005. Molecular characterization and time-kill kinetics of Streptococcus pneumoniae isolates with reduced susceptibility to telithromycin, abstract C1-1418, p. 82.45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, D.C.
3. Appelbaum, P. C. 2002. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin. Infect. Dis. 34:1613-1620.
4. Canton, R., A. Mazzariol, M. I. Morosini, F. Baquero, and G. Cornaglia. 2005. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J. Antimicrob. Chemother. 55:489-495.
5. Canu, A., B. Malbruny, M. Coquemont, T. A. Davies, P. C. Appelbaum, and R. Leclercq. 2002. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:125-131.
6. Clinical Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. Clinical Laboratory Standards Institute, Wayne, Pa.
7. D'Costa, V. M., K. M. McGrann, D. W. Hughes, and G. D. Wright. 2006. Sampling the antibiotic resistome. Science 311:374-377.
8. Douthwaite, S., J. Jalava, and L. Jakobsen. 2005. Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm. Mol. Microbiol. 58:613-622.
9. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
10. Faccone, D., P. Andres, M. Galas, M. Tokumoto, A. Rosato, and A. Corso. 2005. Emergence of a Streptococcus pneumoniae clinical isolate highly resistant to telithromycin and fluoroquinolones. J. Clin. Microbiol. 43:5800-5803.
11. Farrell, D. J., and D. Felmingham. 2004. Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003. Antimicrob. Agents Chemother. 48:1882-1884.
12. Hisanaga, T., D. J. Hoban, and G. G. Zhanel. 2005. Mechanisms of resistance to telithromycin in Streptococcus pneumoniae. J. Antimicrob. Chemother. 56:447-450.
13. Horinouchi, S., W.-H. Byeon, and B. Weisblum. 1983. A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis. J. Bacteriol. 154:1252-1262.
14. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
15. Musher, D. M. 1992. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 14:801-807.
16. Okitsu, N., S. Kaieda, H. Yano, R. Nakano, Y. Hosaka, R. Okamoto, T. Kobayashi, and M. Inoue. 2005. Characterization of ermB gene transposition by Tn1545 and Tn917 in macrolide-resistant Streptococcus pneumoniae isolates. J. Clin. Microbiol. 43:168-173.
17. Rantala, M., M. Haanperä-Heikkinen, M. Lindgren, H. Seppälä, P. Huovinen, J. Jalava, and the Finnish Study Group for Antimicrobial Resistance. 2006. Streptococcus pneumoniae isolates resistant to telithromycin. Antimicrob. Agents Chemother. 50:1855-1858.
18. Reinert, R. R., C. Franken, M. van der Linden, R. Lütticken, M. Cil, and A. Al-Lahham. 2004. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Int. J. Antimicrob. Agents 24:43-47.
19. Reinert, R. R., M. R. Jacobs, P. C. Appelbaum, S. Bajaksouzian, S. Cordeiro, M. van der Linden, and A. Al-Lahham. 2005. Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones. J. Clin. Microbiol. 43:6035-6041.
20. Reinert, R. R., S. Muckel, A. Al-Lahham, B. G. Spratt, A. B. Brueggemann, R. Hakenbeck, and R. Lutticken. 2003. Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing. J. Med. Microbiol. 52:981-987.
21. Reinert, R. R., A. Wild, P. Appelbaum, R. Lutticken, M. Y. Cil, and A. Al-Lahham. 2003. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany. Antimicrob. Agents Chemother. 47:2319-2322.
22. Tait-Kamradt, A., T. Davies, M. Cronan, M. R. Jacobs, P. C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.
23. Walsh, F., J. Willcock, and S. Amyes. 2003. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. J. Antimicrob. Chemother. 52:345-353.